Utilize the data and tweets at hand to foresee if the closing price of $agn will elevate or diminish at 2017-03-30. Only answer with Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-03-16,0.8,0.8,-0.3,-0.5,-0.5,0.4,0.6,1.2,1.6,1.9,1.1
2017-03-17,0.6,1.3,-0.1,-0.9,-0.9,0.9,1.1,1.9,2.3,2.7,2.1
2017-03-20,0.4,0.4,-0.2,-0.2,-0.2,0.8,1.1,1.8,2.3,2.7,2.4
2017-03-21,1.1,1.7,-0.1,-1.0,-1.0,1.4,1.9,2.5,3.1,3.5,3.5
2017-03-22,0.1,1.0,-0.3,-0.2,-0.2,1.1,1.9,2.5,3.1,3.6,3.8
2017-03-23,-0.5,0.8,-1.0,0.6,0.6,0.1,1.1,1.6,2.3,2.8,3.1
2017-03-24,-0.8,0.4,-1.0,0.9,0.9,-0.7,0.1,0.5,1.2,1.7,2.1
2017-03-27,-1.7,0.5,-1.8,0.9,0.9,-1.4,-0.8,-0.4,0.2,0.7,1.1
2017-03-28,-0.5,0.3,-0.5,0.5,0.5,-1.3,-1.2,-0.9,-0.3,0.2,0.6
2017-03-29,-0.3,0.7,-0.4,0.3,0.3,-1.1,-1.5,-1.2,-0.8,-0.3,0.2

2017-03-16: #allergan cramer on how investors should maneuver amid ceo buybacks. read more:  $agn|#allergan cramer on how investors should maneuver amid ceo buybacks. read more:  $agn|rt AT_USER phenomenal stock 
2017-03-17: AT_USER buyout is a definitely. look at $tbra buyout from $agn, $cerc, $innl $exel|AT_USER added to $regn today.  $agn got my eye also.  consolidating nicely back to the moving averages.|AT_USER as pa
2017-03-18: AT_USER would be sweet if $agn comes in and sweeps up $auph at 1.7b +++|hoping $auph partners voclo in ln for c.$1.2bn, keeping dry eye for itself. $agn's restasis sells ~$1.5bn/yr. voclo the superior
2017-03-19: projected weekly ranges in select stocks (mar 20-24): $aapl $agn $amzn $bac $fb $goog $gild $nflx $nvda $tsla $spy¡­ |rt AT_USER first look at projected weekly ranges in select stocks: $aapl $agn $amz
2017-03-20: $edit, $agn, $edit editas get a vetr upgrade to strong buy - |rt AT_USER lilly takes a stab at pricing transparency, but is it enough of the right data?  #pharma $lly $mrk $j¡­|#allergan brief-juv&amp
2017-03-21: assuming the market doesn't completely fall apart, $agn, looks a lot like a cup and handle pattern. just had a good¡­ |AT_USER AT_USER $hlf $agn you can't make this shit up. |rt AT_USER lilly takes a 
2017-03-22: rt AT_USER $ibb $xbi $celg $agn $amgn $regn $gild can't stress the importance of this video enough! $study |$ibb $xbi $celg $agn $amgn $regn $gild can't stress the importance of this video enough! $st
2017-03-23: {new video} biotech analysis + trade ideas: $ibb $xbi $celg $regn $amgn $agn $gild --&gt;  |hey funny buddies AT_USER AT_USER AT_USER these were my 5 best performing #stocks today: $snap $kors $sq $cx
2017-03-24: can anyone challenge allergan in medical-aesthetics market? $agn  $holx $jnj $vrx $zltq $cyno $endp|will gop pass healthcare vote? (poll)  $amgn $gild $celg $aet $agn $azn $vrx $jnj $abbv |good articl
2017-03-25: $agn^a get 14 days #free #premium access on the #1 #stock #app &amp; #trump competition:  #nyctaf #ultra2017|$agn get 14 days #free #premium access on the #1 #stock #app &amp; #trump competition:  #ny
2017-03-26: marketplace roundtable: biotech hanging in the balance  $teva $agn $vrx $azn $acad $ibb $exel $dvax $exas $xbi|rt AT_USER top 10 overbought names in $spy: $noc $rop $has $amg $aapl $agn $rht $prgo $bm
2017-03-27: $agn nice bounce on 50d ma |$agn (weekly) - p/b has ended on the 10wk ma; i'm long. |AT_USER AT_USER AT_USER in this battle of biotechnology plays,  $agn is by far the clear winner. $vrx is a toxic in
2017-03-28: 247.50 lotto on weekly $agn. lets go|rt AT_USER the AT_USER oks $agn allergan's long-duration next-gen ha filler for nasolabial folds  via AT_USER|wednesday: $rh, $cbio, $shld, $akao, $aapl, $fb, $agn
2017-03-29: rt AT_USER who's headed to the #fastmoneymadness finals? AT_USER with $nvda or AT_USER with $agn?|allergan plc $agn shares sold by teachers advisors llc |rt AT_USER who's headed to the #fastmoneymadne
Answer:
Fall